FN3K-MYO16 Fusion FISH Probe
The FN3K-MYO16 Fusion FISH Probe is used to confirm a fusion of the FN3K and MYO16 genes. The fusion of the FN3K and MYO16 genes has been associated with Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FN3K-MYO16-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FN3K-MYO16-20-AQAQ | 20 (40 μL) | 200 μL |
|
MYO16 Gene Summary
This gene encodes an unconventional myosin protein. The encoded protein has been proposed to act as a serine/threonine phosphatase-1 targeting or regulatory subunit. Studies in a rat cell line suggest that this protein may regulate cell cycle progression. A variant within this gene may be associated with susceptibility to schizophrenia and elevated expression of this gene has been observed in the frontal cortex of human schizophrenia patients. [provided by RefSeq, Mar 2017]
Gene Name: Myosin XVI
Chromosome: CHR13: 109248499 -109860355
Locus: 13q33.3
FN3K Gene Summary
A high concentration of glucose can result in non-enzymatic oxidation of proteins by reaction of glucose and lysine residues (glycation). Proteins modified in this way, fructosamines, are less active or functional. This gene encodes an enzyme which catalyzes the phosphorylation of fructosamines which may result in deglycation. [provided by RefSeq, Feb 2012]
Gene Name: Fructosamine 3 Kinase
Chromosome: CHR17: 80693451 -80709073
Locus: 17q25.3
Gene Diseases
The FN3K MYO16 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|